Biomay at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Biomay brings 3 presentations to ESGCT 2026 in Hamburg. Its contribution is manufacturing chemistry for nucleic acid medicines. Work covers a GMP platform for enzymatically made DNA, fed-batch in vitro transcription that raises messenger RNA yield and cuts cost, and mass spectrometry checks on RNA formulated in lipid nanoparticles.
| Organization | ESGCT 2026 Attendance |
|---|---|
Biomay Vienna, Austria | |
GMP contract manufacturer of plasmid DNA, mRNA and recombinant proteins, including enzymatically synthesized DNA. | Poster Wed Oct 28 1:30pm–3:30pm Analysis of critical quality attributes of mRNA formulated in lipid nanoparticles by mass spectrometry Poster Thu Oct 29 2:00pm–4:00pm Establishment of a cGMP manufacturing platform for enzymatically synthesized DNA Poster Thu Oct 29 2:00pm–4:00pm Manufacturing of mRNA by fed-batch in vitro transcription: a strategy for substantial cost reduction, improved yield and product quality |
Instantly find 20 buyers from Biomay
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction